Back
Apellis Pharmaceuticals Vs. Xometry Industry Stock Comparison
Sell
42
APLS
Apellis Pharmaceuticals
Last Price:
28.89
Seasonality Move:
22.1%
Buy
60
XMTR
Xometry
Last Price:
30.62
Seasonality Move:
21.1%
Sell
42
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
- The current Apellis Pharmaceuticals [APLS] share price is $28.08. The Score for APLS is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- APLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Xometry (XMTR)
is a Buy
Is Xometry a Buy, Sell or Hold?
- The current Xometry [XMTR] share price is $25.84. The Score for XMTR is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- XMTR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $28.08
The current trend is relatively stagnant and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.
APLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.87 | Sell |
| Relative Strength Index (14 RSI): | 45.96 | Sell |
| Chaikin Money Flow: | 8609149 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.04 - 28.04) | Buy |
| Bollinger Bands (100): | (30.03 - 39.99) | Sell |
XMTR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.14 | Buy |
| Relative Strength Index (14 RSI): | 76.63 | Buy |
| Chaikin Money Flow: | 752791 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.48 - 21.52) | Buy |
| Bollinger Bands (100): | (13.56 - 19.92) | Buy |
APLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.62 | Buy |
| 20-day SMA: | 27.47 | Buy |
| 50-day SMA: | 31.83 | Sell |
| 200-day SMA: | 44.76 | Sell |
| 8-day EMA: | 27.81 | Buy |
| 20-day EMA: | 28.14 | Sell |
| 50-day EMA: | 30.87 | Sell |
| 200-day EMA: | 40.98 | Sell |
XMTR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.19 | Buy |
| 20-day SMA: | 20.01 | Buy |
| 50-day SMA: | 19.15 | Buy |
| 200-day SMA: | 18.81 | Buy |
| 8-day EMA: | 21.9 | Buy |
| 20-day EMA: | 20.49 | Buy |
| 50-day EMA: | 19.11 | Buy |
| 200-day EMA: | 18.83 | Buy |
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.29 per share, and an increase next year of $1.33 per share.
Xometry Earnings Growth & XMTR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.13 per share, and an increase next year of $0.37 per share.
Apellis Pharmaceuticals Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Xometry Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||